Primary Site >> Liver Cancer
Gene >> ARID1A
|
|
|
|
|
|
|
|
|---|---|---|---|---|---|---|---|
|
Ref: Characterization of SWI/SNF protein expression in human breast cancer cell lines and other malignancies. PMID: 11147808 |
Ref: Integrated analysis of somatic mutations and focal copy-number changes identifies key genes and pathways in hepatocellular carcinoma. PMID: 22561517 Ref: Whole-genome sequencing of liver cancers identifies etiological influences on mutation patterns and recurrent mutations in chromatin regulators. PMID: 22634756 Ref: Exome sequencing of hepatitis B virus-associated hepatocellular carcinoma. PMID: 22922871 Ref: Next-generation sequencing identified new oncogenes and tumor suppressor genes in human hepatic tumors. PMID: 23264911 |
Ref: Target genes discovery through copy number alteration analysis in human hepatocellular carcinoma. PMID: 24379610 |
Ref: Genomic and transcriptional alterations of cholangiocarcinoma. PMID: 24532422 Ref: New routes to targeted therapy of intrahepatic cholangiocarcinomas revealed by next-generation sequencing. PMID: 24563076 Ref: Influence of adriamycin on changes in Nanog, Oct-4, Sox2, ARID1 and Wnt5b expression in liver cancer stem cells. PMID: 24944491 Ref: Diverse modes of genomic alteration in hepatocellular carcinoma. PMID: 25159915 |
Ref: Decreased expression of ARID1A associates with poor prognosis and promotes metastases of hepatocellular carcinoma. PMID: 25975202 Ref: Genetic Landscape and Biomarkers of Hepatocellular Carcinoma. PMID: 26099527 Ref: New molecular therapies for hepatocellular carcinoma. PMID: 26206572 Ref: Comparative transcriptome analysis reveals that the extracellular matrix receptor interaction contributes to the venous metastases of hepatocellular carcinoma. PMID: 26271415 Ref: Microarray profiling shows distinct differences between primary tumors and commonly used preclinical models in hepatocellular carcinoma. PMID: 26520397 Ref: Hepatocyte-Specific Arid1a Deficiency Initiates Mouse Steatohepatitis and Hepatocellular Carcinoma. PMID: 26569409 Ref: Hepatocellular Carcinoma in Noncirrhotic Liver with Glycogenotic Foci: Basic Science Meets Genomic Medicine. PMID: 26676821 |
Ref: TERT promoter mutations in primary liver tumors. PMID: 26336998 Ref: The Clinicopathologic Significance of BAF250a (ARID1A) Expression in Hepatocellular Carcinoma. PMID: 26589513 Ref: The landscape of targeted therapies for cholangiocarcinoma: current status and emerging targets. PMID: 27102149 Ref: Modeling Gene Regulation in Liver Hepatocellular Carcinoma with Random Forests. PMID: 27818995 |
Ref: Mutational landscape of combined hepatocellular carcinoma and cholangiocarcinoma, and its clinicopathological significance. PMID: 27634656 Ref: Frequently mutated genes/pathways and genomic instability as prevention targets in liver cancer. PMID: 27838634 Ref: Constitutional and functional genetics of human alcohol-related hepatocellular carcinoma. PMID: 28296015 Ref: Integrative Genomic Analysis of Cholangiocarcinoma Identifies Distinct IDH-Mutant Molecular Profiles. PMID: 28297679 Ref: Genomic and Epigenomic Heterogeneity of Hepatocellular Carcinoma. PMID: 28302680 Ref: Frequency and geographic distribution of TERT promoter mutations in primary hepatocellular carcinoma. PMID: 28529542 Ref: Common Molecular Subtypes Among Asian Hepatocellular Carcinoma and Cholangiocarcinoma. PMID: 28648284 Ref: ARID1A represses hepatocellular carcinoma cell proliferation and migration through lncRNA MVIH. PMID: 28716731 Ref: GATA4 loss of function in liver cancer impedes precursor to hepatocyte transition. PMID: 28758902 Ref: The biology of Hepatocellular carcinoma: implications for genomic and immune therapies. PMID: 28854942 Ref: A Two-Faced mSWI/SNF Subunit: Dual Roles for ARID1A in Tumor Suppression and Oncogenicity in the Liver. PMID: 29136498 Ref: Arid1a Has Context-Dependent Oncogenic and Tumor Suppressor Functions in Liver Cancer. PMID: 29136504 |
Ref: ARID1A Has Context-Specific Roles in Hepatocellular Carcinoma. PMID: 29167107 Ref: Arid1a Has Context-Dependent Oncogenic and Tumor Suppressor Functions in Liver Cancer. PMID: 29316428 Ref: Whole-exome mutational and transcriptional landscapes of combined hepatocellular cholangiocarcinoma and intrahepatic cholangiocarcinoma reveal molecular diversity. PMID: 29408647 Ref: A human-specific switch of alternatively spliced AFMID isoforms contributes to TP53 mutations and tumor recurrence in hepatocellular carcinoma. PMID: 29449409 Ref: Next-Generation Sequencing of Circulating Tumor DNA Reveals Frequent Alterations in Advanced Hepatocellular Carcinoma. PMID: 29487225 Ref: Molecular genomic landscapes of hepatobiliary cancer. PMID: 29573058 Ref: VI consensus document by the Spanish Liver Transplantation Society. PMID: 29776591 Ref: VI consensus document by the Spanish Liver Transplantation Society. PMID: 29866511 Ref: Emergence of Intrahepatic Cholangiocarcinoma: How High-Throughput Technologies Expedite the Solutions for a Rare Cancer Type. PMID: 30158952 Ref: Differentiation therapy and the mechanisms that terminate cancer cell proliferation without harming normal cells. PMID: 30190481 Ref: Multi-modal meta-analysis of 1494 hepatocellular carcinoma samples reveals significant impact of consensus driver genes on phenotypes. PMID: 30242023 |